The Company and Basis of Presentation - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | |||||
|---|---|---|---|---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
Dec. 31, 2021 |
Feb. 28, 2021 |
Dec. 31, 2020 |
Jul. 15, 2020 |
|
| Subsidiary, Sale of Stock [Line Items] | ||||||
| Number of warrants (in shares) | 5,636,801 | 5,636,801 | ||||
| Proceeds from sales of common stock, net of issuance costs | $ 0 | $ 29,705 | ||||
| Warrants | ||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||
| Number of warrants (in shares) | 3,840,000 | 2,160,000 | 2,160,000 | |||
| Warrants | Common Stock | ||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||
| Exercise price per share (in dollars per share) | $ 2.25 | $ 4.00 | $ 4.00 | |||
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|